🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A 52-week safety and efficacy study of simufilam (PTI-125) given twice dail...
Status
Completed
Location
MDFirst Research
Start Date
2021-11-03
Trial ID
NCT04994483
The purpose of this study is to evaluate the efficacy, immunogenicity and s...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-10-01
Trial ID
NCT01439360
The purpose of the VBE00009 study is to evaluate the safety, efficacy and i...
Status
Recruiting
Location
Encino Research Center- Site Number : 8400008
Start Date
2025-07-03
Trial ID
NCT07013747
Treatments Being Tested
This was a prospective, randomized, double-blinded, multicenter, pivotal st...
Status
Completed
Location
CECOR - Centro Oncológico de Roraima
Start Date
2022-02-14
Trial ID
NCT04650399
The goal of this clinical trial is to test the safety and immunogenicity of...
Status
Completed
Location
Cenexel ACT (Anaheim Clinical Trials)
Start Date
2024-01-26
Trial ID
NCT06221813
Treatments Being Tested
This study is designed to evaluate efficacy, immunogenicity and safety of v...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-05-24
Trial ID
NCT03162614
Treatments Being Tested
This study will evaluate the safety of candidate malaria vaccine MSP3 in ch...
Status
Unknown
Location
Kwashemshi village
Start Date
2007-10
Trial ID
NCT00469651
Phase IIb clinical trial to assess the Immunogenicity and Safety of a HIPRA...
Status
Completed
Location
Hospital HM Modelo
Start Date
2022-03-25
Trial ID
NCT05305573
This study will test the safety and immunogenicity of the gp120/NefTat/AS02...
Status
Completed
Location
Massacusetts General Hospital -Infectious Disease Unit
Start Date
2005-06
Trial ID
NCT00117429
Treatments Being Tested